Viatris Eyes Gilenya Generic Following ‘Unreliable’ Study Data
Firm Also Backed For Zytiga Generic By CHMP
Viatris has bounced back from withdrawing its application for a generic version of Gilenya in the EU with a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use.
